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to antibiotic administration and other time-sensitive
measures. We hypothesize that triage support will
decrease time to vitals, blood cultures, antibiotics, and
unit transfer.
Methods: A before-after interventional study was conducted
of all adult (age  18) patients with history of BMT and fever
>37.1C admitted from a 60,000-visit university ED with an
active BMT program between October 2011 and July 2014.
Cohorts were deﬁned by implementation of a computerized
triage support advisory in February 2013. This system was
comprised of a best practice advisory (BPA) using both a
computer prompt and an automated page to alert clinicians
to the history of recent BMT. The primary outcome was time
to antibiotics, and secondary outcomes included time to vital
signs, blood cultures, and transfer. A one-sided Wilcoxon
rank-sum test was used to compare before-after intervention
times, and the Chi-squared test was used for comparisons of
proportions. Statistical tests were assessed for signiﬁcance at
the 5% level.
Results: Sixty-three patients were included in the study, and
most had blood cultures drawn and antibiotics started
empirically (87% and 86%, respectively). Median time to an-
tibiotics was lower after BPA implementation (79 vs. 114 min,
p<0.01). Despite earlier antibiotic administration, the rate of
blood cultures (85% after vs. 92% before, p¼0.67) and anti-
biotics (87% vs. 83%, p¼0.96) did not change. No differences
were observed in time to vital signs, blood culture, or ED
disposition did not change.
Conclusion: Computerized triage support was associated
with decreased time to antibiotics, without increased health
care utilization. Further studies designed to better under-
stand the role of enhanced triage tools and EMR screening
protocols are critical to standardizing care and identifying
patients at high risk of clinical deterioration.519
Meeting Retrospective: Deﬁning Quality and Value in
Stem Cell Transplant 2014 Forum
Alicia Silver 1, StephanieA. Farnia 2. 1 Payer Policy & Legislative
Relations, NMDP/Be The Match, Minneapolis, MN; 2 Payer
Policy, National Marrow Donor Program, Minneapolis, MN
In July 2014, the National Marrow Donor Program/Be The
Match’s (NMDP) Advisory Group on Financial Barriers to
Transplant convened a working forum in Minneapolis,
MN attended by over 100 stem cell transplant (SCT)
community representatives. Forum participants included
transplant center medical and program directors, national
payers and reinsurers and leadership from the Founda-
tion for the Accreditation of Cellular Therapy (FACT), the
American Society of Blood and Marrow Transplant
(ASBMT) and the Center for International Blood and
Marrow Transplant (CIBMTR). Speakers at the forum
discussed their perspectives on how the SCT ﬁeld can
develop approaches to measure quality and improve
value for patients. At the conclusion of the forum many
recommendations for the SCT community emerged
through several roundtable and full group discussions. (1)
The SCT community needs to develop a stronger rela-
tionship with referring physicians to ensure timely pa-
tient referral to transplant which is associated with better
outcomes. Early referral could serve as a quality metric
for the hematologic community tied to the patient’soverall care experience. Payer engagement in referral
timing is an underutilized potential resource. (2) Leverage
data available to transplant centers from the CIBMTR’s
Stem Cell Transplant Outcomes Database (SCTOD) to
identify utilization patterns that need further study. (3)
SCT community leadership and organizations should
develop a venue for ongoing dissemination and discus-
sion of promising care in SCT that take into account FACT
ﬁndings, SCTOD analysis and ASBMT guidelines for overall
quality improvement. (4) Develop draft SCT quality
measures and test them among transplant centers. (5)
Identify components of quality measurement in SCT that
would be appropriate for use in quality or outcome based
reimbursement models. (6) Engage other communities in
the quality measure development process including the
physician societies like the American Society of Hema-
tology and the American Society of Clinical Oncology, the
National Quality Forum as well as employers, patients,
pharmaceutical manufactures and hospital level admin-
istrators and Chief Financial Ofﬁcers. Forum participants
found the meeting to be very engaging and useful for
their daily work in the SCT ﬁeld. A follow-up meeting is
scheduled for July 2015 in Minneapolis, MN where com-
munity speakers will present updates on quality measure
development.520
Experiences with Design and Implementation of a
Related Donor Coordinator Position
Lizeth Garcia-Jennings. Blood & Marrow Transplant Program,
University of Iowa Hospitals & Clinics, Iowa City, IA
Purpose: At our center, related donors were cared for by our
Patient Coordinators. In 2012, we decided to create a new
position, a Donor Coordinator position, which was modeled
after the NMDP workup specialist position. Our goal was to
provide related donors with the same education, care, and
emotional support that unrelated donors receive through the
National MarrowDonor Program (NMDP).We alsowanted to
improve the overall donor experience and service that the
donors receive. Also, due to FACT standards, we found it
necessary to create separate care teams for the donors and
recipients, while also being able to offer a donor advocate to
all donors.
Scope: We evaluated a related donor’s journey from initial
testing to follow-up. Key issues found were education prior
to testing, donor safety based on past medical history, and
administration of ﬁlgrastim.
Method: The Donor Coordinator position is in charge of the
donor’s care and conﬁrms separate teams for the donor and
recipient, while also serving as an advocate.
Education prior to initiation of testing was a main goal. A
health history questionnaire and educational documents
were created for the initial screening, testing, and education
of donors. Donors are educated of the whole process by
phone prior to testing and are screened by the Donor
Coordinator. Screening of donors is performed with a
standard health history questionnaire. Any medical condi-
tions that are present are reviewed by the Donor Coordi-
nator who consults the NMDP’s Medical Assessment at HR/
CT/WU. If the NMDP assessment suggests a deferral, then
the Donor Coordinator will send this information to our
Transplant Physician to make the ﬁnal decision on whether
to proceed with testing. If there are no concerns regarding a
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monitored phone call for consent, or by mailing the consent.
Once we receive consent for tissue typing, then we proceed
with testing.
When a matched related donor is found, the Donor
Coordinator performs an information session prior to their
medical evaluation. This helps donors feel comfortable with
the donation and helps answer all of their logistical ques-
tions prior to seeing our clinical team.
Once cleared, the Donor Coordinator arranges for the
donors ﬁlgrastim injections to be given by a home healthcare
nurse.
Results/Conclusions: Our program has received great feed-
back from donors since we started the Donor Coordinator
position. We have been able to work through donor concerns
in a privatemanner.We have chosen not to test or use donors
based on their concerns and this position has helped with
family dynamics. Many of these steps have helped donors
feel that they are important in this process and has helped
them feel comfortable with the whole donation. We are in
the process of creating a survey to assess the donor’s expe-
rience with the Donor Coordinator, our medical team, and
the donation process.Figure 1. Current state521
Improving Channels of Communication to Ensure
Multidisciplinary Knowledge and Participation in BMT
Quality and Process Improvement
Amanda K. Hrnicek. Blood and Marrow Transplant Program,
The Ohio State University Wexner Medical Center, James
Cancer Hospital., Columbus, OH
Introduction: Quick and effective communication regarding
information that is constantly evolving is a critical compo-
nent of quality patient care and safety. In order to improve
communication and ensure understanding regarding new/
revised policies and performance improvement initiatives, a
BMT quality newsletter and quiz tool was implemented.
Methods: From (09/2013) through (10/2014) a “Spotlight on
Quality” newsletter was electronically distributed to all staff
within the BMT Program, including MDs, RNs, BMT Co-
ordinators, Nurse Practitioners, Apheresis Staff, Hematology
Clinic Staff, Clinical Trials staff, Cell Therapy Lab staff, and
other ancillary/support roles. This newsletter allowed them
to receive education and updates regarding policy changes,
accreditation standards, staff recognition, departmental an-
nouncements, and quality projects/initiatives underway. The
newsletter also contained a “Quiz Egg” link that staff was
required to complete, allowing for standard documentation
of policy training while also having the ability to tabulate the
results and assess for general understanding of the changes
being introduced.
Results: Staff reported inclusive knowledge regarding BMT
Program initiatives and policy changes as also evidenced by a
72% mean quiz completion amongst BMT Quality Committee
members. Those departments that have taken the opportu-
nity to use the newsletter for communicating departmental
changes to the program felt well recognized and understood.
From a quality perspective, lack of understanding regarding a
policy change or initiative was gleaned from the quiz results
based upon the tabulation provided of % of correct responses
for each question. Lastly, staff expressed a greater willingness
to get involved in quality improvement opportunities when
they are well informed of initiatives.Conclusion: A consistent method of communication
distributed to the entire BMT Program has formalized pro-
grammatic changes and has placed quality initiatives at the
forefront while allowing for improved multidisciplinary
communication. Information is clearly communicated and
with the quiz tool, staff training and comprehension is
clearly measured.522
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Virginia School of Medicine, Charlottesville, VA; 4 Stem Cell
Transplant, University of Virginia, Charlottesville, VA;
5 University of Virginia, Charlottesville, VA
Background: The University of Virginia Health System‘s
(UVA) mission is to be the safest place in health care for
patients and employees. The BE SAFE initiative outlines how
to identify problems related to patient and employee safety
via the A3 problem solving tool. A3 methodology is a Lean
process improvement system that standardizes workﬂows
by removing unnecessary or wasteful practices, thereby
increasing efﬁciency of healthcare delivery. In support of the
BE SAFE initiative, we examined our hematopoietic stem cell
transplant (HSCT) inpatient consultation process using our
electronic medical record (EMR) at UVA. Full implantation of
the EMR at UVA occurred in March 2011 using EPIC Hyper-
space software.
Methods: A multidisciplinary team including social worker,
ﬁnancial coordinator, quality coordinator, program admin-
istrator, physicians and transplant coordinators conducted
an audit of all inpatient HSCT consults requested from July
2013 to July 2014 examining the process from initial consult
to transplant workup. Algorithms were created in Microsoft
Visio to represent our current state and target state for the
consultation process. Through the A3 process, we identiﬁed
